Key result
Telmisartan significantly inhibits Ang II- and estradiol-induced leiomyoma cell proliferation in vitro.
Why the study?
The pathophysiology of uterine leiomyomas is poorly understood, and elevated blood pressure is independently associated with increased risk of clinically detected uterine leiomyoma.
p-value: p=<0.01
In vitro findings demonstrate that the AT1R blocker telmisartan represses Angiotensin II-induced proliferation of rat leiomyoma cells, suggesting a potential mechanism linking elevated blood pressure and uterine fibroids.
No takes yet. Share an insight, caveat, or question.
Caution against clinical use in fibroids; hypothesis-generating for AT1R blockade linking hypertension and leiomyomas.
ISOBE et al. (2007) studied Uterine leiomyoma. Angiotensin II and telmisartan was evaluated on Cell proliferation (p=<0.01). The AT1 receptor blocker telmisartan effectively repressed Angiotensin II-induced and estradiol-induced proliferation of rat ELT-3 leiomyoma cells in vitro (P < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: